Abstract
One crucial factor in ensuring successful outcomes after pancreas transplants is the comprehensive pretransplant evaluation of potential recipients. Proper patient selection is obviously key in any transplant procedure. But, identifying obvious contraindications or excluding poor candidates is only one small aspect of the pretransplant evaluation. Candidates classified as “high risk” may not necessarily have absolute contraindications to surgery; with proper preparation, they can expect to have a good chance for a successful outcome posttransplant. Therefore, a more important goal of the pretransplant evaluation should be to prepare the potential recipient so that he or she is in the best possible condition by the time the transplant is performed. This preparation involves identifying any significant risk factors that could be altered and dealing with medical problems that may lead to complications peri- or posttransplant. Even risk factors that cannot be altered are best identified pretransplant because they may affect posttransplant care. The potential recipient must also be psychologically prepared for the transplant, ideally through providing education on the many different aspects of transplantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sutherland DER, Gruessner RGW, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner A. Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients. Transplant Proc 2001; 33: 1656–1658.
Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742–747.
Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, Lundin PA, and Murphy KJ. The evaluation of renal transplant candidates- Clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1–34.
Quinibi WY, Al-Sibai MB, Taher S, et al. Mycobacterial infection after renal transplantation-report of 14 cases and review of the literature. Q J Med 1990; 77: 1039–1060.
Rubin RH, Jenkins RL, Shaw BS Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1–4.
Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant 2001; 1: 13–17.
Weir MR, Irwin BC, Maters AW, et al. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor-recipient pre-transplant immunity. Transplantation 1987; 43: 187–191.
Green M. Management of Epstein-Barr virus induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001; 1: 103–108.
Hiesse C, Buffet C, Neyrat N, et al. Impact of hepatitis B antigenemia on long-term patient survival and causes of death after renal transplantation. Clin Transplant 1992; 46: 461–467.
Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C-its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273–276.
Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667–670.
Popkin MK, Callies AL, Lentz RD, et al. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 1998; 45: 64–68.
Popkin MK, Callies AL, Colon EA. Psychiatric diagnosis and the surgical outcome of pancreas transplantation in patients with type I diabetes mellitus. Psychosomatics 1993; 34: 251–258.
Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low-risk subgroup. Kidney Int 1993; 44: 617–621.
Vandenberg BF, Rossen JD, Grover-McKay M, et al. Evaluation of diabetic patients for renal and pancreas transplantation: Noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 1996; 62: 1230–1235.
Bates JR, Sawada SG, Segar DS, Spaedy AJ, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77: 175–179.
Herzog CA, Marwick TH, Pheley AM, White C, et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33: 1080–1090.
Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998–1002.
Kalker AJ, Pirsch JD, Heisey D, et al. Foot problems in diabetic transplant recipients. Clin Transplant 1996; 10: 503–510.
Brown MM, Humphrey PR. Carotid endarterectomy-specific therapy based on pathophysicology. N Engl J Med 1991; 325: 505–507.
Chiu MY, Sprague SM, Bruce DS, Woodle ES, et al. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 1998; 9: 677–683.
Humar A, Kandaswamy R, Drangstveit MB, et al. Surgical complications in obese pancreas transplant recipients. Transplantation 2000; 69: S212.
Humar A, Kandaswamy R, Ramcharan T, et al. A multivariate analysis of risk factors for acute rejection in pancreas transplant recipients. Am J Transplant 2001; 1 (suppl 1): 212.
Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplant. Am J Surg 2001; 182 (2): 155–161.
Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463–501.
Farney AC, Cho E, Schweitzer E, et al. Simultaneous cadaver pancreas living-donor kidney transplantation: A new approach for the type 1 diabetic uremic patient. Ann Surg 2000; 232: 696–703.
Gruessner RW, Sutherland DE, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors: Short-and long-term outcomes. Transplant Proc 2001; 33 (1/2): 819–820.
Humar A, Gruessner R, Sutherland D. Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 1997;53(4).
Gruessner RW, Dunn DL, Gruessner AC, Matas M, Najarian JS, Sutherland DE. Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 1994; 57: 1598–1606.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Khwaja, K., Humar, A. (2004). Pretransplant Evaluation and Cardiac Risk Assessment. In: Gruessner, R.W.G., Sutherland, D.E.R. (eds) Transplantation of the Pancreas. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4371-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4371-5_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1830-7
Online ISBN: 978-1-4757-4371-5
eBook Packages: Springer Book Archive